查找临床试验
已按「干眼症」检索，对应国际通用词 dry eye disease
共找到 42 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步Phase III Study of OT202 in Treating Moderate to Severe Dry Eye
China
年龄 30 Years – 75 Years
Ocumension Therapeutics (Suzhou) Co., Ltd
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 65 Years
Peking University People's Hospital
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
United States、Australia、Canada、China、Colombia 等 6 国
年龄 18 Years – 100 Years
Novartis Pharmaceuticals
Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease Management
Hong Kong
年龄 18 Years – 60 Years
The Hong Kong Polytechnic University
Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xiamen University
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
China
年龄 18 Years – 70 Years
Peking University People's Hospital
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 80 Years
Peking University Third Hospital
Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)
China
年龄 18 Years – 不限
Chen Wei
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
China
年龄 18 Years – 不限
Antengene Biologics Limited
3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Hong Kong
年龄 6 Years – 不限
The University of Hong Kong
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
China
年龄 18 Years – 65 Years
Therorna
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
China
年龄 18 Years – 70 Years
Nanjing Bioheng Biotech Co., Ltd.